3 Reviews
Benefits are good. If you're a scientist, seems like it's a good place to work (check Glassdoor).
Biossance: micromanagement, toxic leadership team, finger-pointing, disorganization. Poor planning. Leadership changing their mind 2 days before launching a new initiative. All work going to waste because they didn't plan ahead. Not enough room to grow. They expect you to work A LOT and don't give you enough support. No prioritization of projects. Everything is important and needs to be done ASAP, but there aren't enough resources. Everyone is overworked and burned out. I don't know if the president doesn't know about the reality of the team (because the managers are trying to protect their own jobs) or if she doesn't care.
The cannabis industry has struggled, but pot stocks Amyris, Jazz Pharmaceuticals and Innovative Industrial Properties could jump on regulation reform.
Report Scope This latest report researches the industry structure capacity production sales consumption revenue price and gross margin Major producers production locations market shares industry ranking and profiles are presented The primary and secondary research is done in order to ...